ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Simon C. Moten
Brian Buxton
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moten, S. C.
Right arrow Articles by Buxton, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moten, S. C.
Right arrow Articles by Buxton, B.
Related Collections
Right arrow Extracorporeal circulation
Right arrowRelated Article

Ann Thorac Surg 2005;80:303
© 2005 The Society of Thoracic Surgeons

New technology

Invited Commentary

Simon C. Moten, MDa, Brian Buxton, FRACSb

a Cardiothoracic Surgery, Brody School of Medicine, East Carolina University, Greenville, NC 27858
b Department of Cardiac Surgery, Austin Hospital, HSB-5, Studley Rd, Heidelberg, Melbourne, Victoria, Australia 3084

(Email: motens@mail.ecu.edu; brian.buxton@austin.org.au).

The first 20% of the full text of this article appears below.

Heparin-induced thrombocytopenia (HIT) is a potential life threatening complication of heparin therapy, in particular unfractitionated heparin. Heparin is the mainstay of anticoagulation used for cardiopulmonary bypass thanks to its ease of use, rapid monitoring, short half-life, reversibility, and low cost. As many as 50% of patients have measurable heparin-platelet factor 4 antibody titers develop after cardiac surgery using unfractitionated heparin, but only 1% to 3% have observed HIT (a clinicopathologic diagnosis based on clinical findings, fall in platelet count, and measurable heparin-platelet factor . . . [Full Text of this Article]


Related Article

Preemptive Use of Bivalirudin for Urgent On-Pump Coronary Artery Bypass Grafting in Patients With Potential Heparin-Induced Thrombocytopenia
Cornelius M. Dyke, Andreas Koster, James J. Veale, George W. Maier, Thomas McNiff, and Jerrold H. Levy
Ann. Thorac. Surg. 2005 80: 299-303. [Abstract] [Full Text] [PDF]





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.